13F

MRVI MARAVAI LIFESCIENCES HLDGS-A

2026Q1 · CUSIP 56600D107 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
157
Δ holders QoQ
-4
Breadth percentile
Top 76%
Whale holders
83
Δ whales
+1
Inst. holding value
$343M
New positions
27
Closed positions
31
Price momentum (1Q)
+39.2%
Put / Call
3/4

Breadth history (34 quarters)

2021Q1: Δ+28 · h=142 2021Q2: Δ+52 · h=194 2021Q3: Δ+32 · h=226 2021Q4: Δ+2 · h=228 2022Q1: Δ+4 · h=232 2022Q2: Δ-20 · h=212 2022Q3: Δ-10 · h=202 2022Q4: Δ+11 · h=213 2023Q1: Δ+4 · h=217 2023Q2: Δ+3 · h=220 2023Q3: Δ-16 · h=204 2023Q4: Δ+19 · h=223 2024Q1: Δ-12 · h=211 2024Q2: Δ-3 · h=208 2024Q3: Δ+10 · h=218 2024Q4: Δ-30 · h=188 2025Q1: Δ+1 · h=189 2025Q2: Δ-39 · h=150 2025Q3: Δ+9 · h=159 2025Q4: Δ+2 · h=161 2026Q1: Δ-4 · h=157 2021Q1: holders=142 2021Q2: holders=194 2021Q3: holders=226 2021Q4: holders=228 2022Q1: holders=232 2022Q2: holders=212 2022Q3: holders=202 2022Q4: holders=213 2023Q1: holders=217 2023Q2: holders=220 2023Q3: holders=204 2023Q4: holders=223 2024Q1: holders=211 2024Q2: holders=208 2024Q3: holders=218 2024Q4: holders=188 2025Q1: holders=189 2025Q2: holders=150 2025Q3: holders=159 2025Q4: holders=161 2026Q1: holders=157 -52 -26 +0 +26 +52 127186244 21Q121Q322Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2021Q3 Top 4% -13.0% -15.8%
2021Q2 Top 3% -31.9% -45.9%
2021Q1 Top 12% +43.8% -2.1%

Options Sentiment

Put holders
3
QoQ: +1
Call holders
4
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.71
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
-15.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $243M 2022-09-30: $191M 2022-12-31: $205M 2023-03-31: $79M 2023-06-30: $69M 2023-09-30: $67M 2023-12-31: $74M 2024-03-31: $64M 2024-06-30: $69M 2024-09-30: $69M 2024-12-31: $57M 2025-03-31: $47M 2025-06-30: $47M 2025-09-30: $42M 2025-12-31: $50M 2026-03-31: $66M 2022-09-30: EPS 0.34 2022-12-31: EPS 0.30 2023-03-31: EPS 0.00 2023-06-30: EPS -0.05 2023-09-30: EPS -0.05 2023-12-31: EPS -0.80 2024-03-31: EPS -0.09 2024-06-30: EPS -0.07 2024-09-30: EPS -0.68 2024-12-31: EPS -0.21 2025-03-31: EPS -0.21 2025-06-30: EPS -0.27 2025-09-30: EPS -0.18 2025-12-31: EPS -0.24 2026-03-31: EPS -0.02 0M 121M 243M $M -0.88 -0.25 0.37 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 26 2023-06-30: PE 17.62023-09-30: PE 25.6 16 21 27 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)